SCIENCE GROUP PLC — Transaction in Own Shares 2026

Mar 25, 2026

National Storage Mechanism | Additional information

RNS Number : 9630X

Science Group PLC

25 March 2026

25 March 2026

Science Group plc

(the "Company" or "Science Group")

Transaction in own shares

Science Group plc (AIM:SAG) announces that, on 24 March 2026, it purchased 14,088 of its 1 pence ordinary shares at an average price of 525 pence per share. The highest price paid per share was 525 pence and the lowest price paid per share was 525 pence. The Company purchased these shares through Panmure Liberum Limited.

The number of shares purchased represented 0.03% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 41,340,224.  Science Group holds 4,845,650 shares in treasury.

The figure of 41,340,224 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Panmure Liberum Limited on behalf of the Company as part of the buyback programme.

Number of shares purchased	Transaction price (per share)	Time of transaction	Execution venue
14088	525	15:37:07	AIMX

- Ends -

For further information:

Science Group plc
Sarah Cole, Company Secretary	Tel: +44 (0) 1223 875 200
Panmure Liberum Limited (Nomad and Joint Broker)
Nicholas How, Rupert Dearden	Tel: +44 (0) 20 3100 2000
Peel Hunt LLP (Joint Broker)
Neil Patel, Benjamin Cryer, Kate Bannatyne	Tel : +44(0)20 7418 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSAKQBKOBKDNNB